A tighter archive for life-science signals.
Search once, then narrow by source or topic.
In the clinic for March 2, 2026
In the clinic for March 2, 2026
Other news to note for March 2, 2026
Other news to note for March 2, 2026
Regulatory actions for March 2, 2026
Regulatory actions for March 2, 2026
Uniqure falls as FDA demands new trial for Huntington’s gene therapy
Uniqure falls as FDA demands new trial for Huntington’s gene therapy
Med-tech outlook 2026: exits, financings, headwinds
Med-tech outlook 2026: exits, financings, headwinds
Biggest gainers and losers for Feb. 23-27, 2026
Biggest gainers and losers for Feb. 23-27, 2026
Atrium Tx launches with Avidity's RNA ticker and cardio assets
Atrium Tx launches with Avidity's RNA ticker and cardio assets
Shionogi synthesizes new compounds for malaria
Shionogi synthesizes new compounds for malaria
In the clinic for Feb. 27, 2026
In the clinic for Feb. 27, 2026
Other news to note for Feb. 27, 2026
Other news to note for Feb. 27, 2026
Regulatory actions for Feb. 27, 2026
Regulatory actions for Feb. 27, 2026
Biopharma money raised: Jan. 1-Feb. 26, 2026
Biopharma money raised: Jan. 1-Feb. 26, 2026
Money raised by biopharma
Money raised by biopharma
Changing US FDA trial default a global matter
Changing US FDA trial default a global matter
Pivot Therapeutics develops new AKT1 inhibitors
Pivot Therapeutics develops new AKT1 inhibitors
MRGPRX2 antagonists disclosed in Arcus Biosciences patent
MRGPRX2 antagonists disclosed in Arcus Biosciences patent
CSPC Zhongqi Pharmaceutical Technology discovers EGFR PROTAC degraders
CSPC Zhongqi Pharmaceutical Technology discovers EGFR PROTAC degraders
Prospect Therapeutics identifies new JAK1 and TYK2 inhibitors
Prospect Therapeutics identifies new JAK1 and TYK2 inhibitors
Brand directory, kept in view
A rolling strip of the companies, platforms, CROs and device makers that show up across the coverage.
Open about page